Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor

Proteomics

Volumn 11, Issue 23, 2011, Pages 4529-4540

  Dai, Lan ^a   He, Jintang ^a   Liu, Yashu ^a   Byun, Jaeman ^b   Vivekanandan, Anuradha ^b   Pennathur, Subramaniam ^b   Fan, Xing ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cancer stem cells; Cell biology; Glioblastoma; Label free; Multiple reaction monitoring; Pathway analysis

Indexed keywords

GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; NOTCH RECEPTOR;

ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GLIOBLASTOMA; GLUCOSE METABOLISM; IMMUNOASSAY; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

AMYLOID PRECURSOR PROTEIN SECRETASES; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME INHIBITORS; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; PROTEOME; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 81855166744     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000730     Document Type: Article

References (61)

1. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M. et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987-996.
2. Vescovi, A. L., Galli, R., Reynolds, B. A., Brain tumour stem cells. Nat. Rev. Cancer 2006, 6, 425-436.
3. Read, T. A., Fogarty, M. P., Markant, S. L., McLendon, R. E. et al., Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 2009, 15, 135-147.
4. Ward, R. J., Lee, L., Graham, K., Satkunendran, T. et al., Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res. 2009, 69, 4682-4690.
5. Son, M. J., Woolard, K., Nam, D. H., Lee, J., Fine, H. A., SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4, 440-452.
6. Gilbert, C. A., Ross, A. H., Cancer stem cells: cell culture, markers, and targets for new therapies. J. Cell Biochem. 2009, 108, 1031-1038.
7. Fan, X., Khaki, L., Zhu, T. S., Soules, M. E. et al., NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28, 5-16.
8. Stockhausen, M. T., Kristoffersen, K., Poulsen, H. S., The functional role of Notch signaling in human gliomas. Neuro. Oncol. 2010, 12, 199-211.
9. Fan, X., Matsui, W., Khaki, L., Stearns, D. et al., Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 2006, 66, 7445-7452.
10. Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B. et al., Notch promotes radioresistance of glioma stem cells. Stem Cells 2010, 28, 17-28.
11. Chiba, S., Notch signaling in stem cell systems. Stem Cells 2006, 24, 2437-2447.
12. Fan, X., Eberhart, C. G., Medulloblastoma stem cells. J. Clin. Oncol. 2008, 26, 2821-2827.
13. Steiniger, S. C., Coppinger, J. A., Kruger, J. A., Yates 3rd, J., Janda, K. D., Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells 2008, 26, 3037-3046.
14. Bendall, S. C., Hughes, C., Campbell, J. L., Stewart, M. H. et al., An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol. Cell. Proteomics 2009, 8, 421-432.
15. Williamson, A. J., Smith, D. L., Blinco, D., Unwin, R. D. et al., Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis. Mol. Cell. Proteomics 2008, 7, 459-472.
16. Dai, L., Li, C., Shedden, K. A., Lee, C. J. et al., Quantitative proteomic profiling studies of pancreatic cancer stem cells. J. Proteome Res. 2010, 9, 3394-3402.
17. Kitteringham, N. R., Jenkins, R. E., Lane, C. S., Elliott, V. L., Park, B. K., Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 1229-1239.
18. Prakash, A., Tomazela, D. M., Frewen, B., Maclean, B. et al., Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. J. Proteome Res. 2009, 8, 2733-2739.
19. Lopez, M. F., Kuppusamy, R., Sarracino, D. A., Prakash, A. et al., Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum. J. Proteome Res. 2011, 10, 133-142.
20. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B. et al., Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64, 7011-7021.
21. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
22. Dai, L., Li, C., Shedden, K. A., Misek, D. E., Lubman, D. M., Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis 2009, 30, 1119-1131.
23. Liu, J. W., Jiao, N. Z., Hong, H. S., Luo, T. W., Cai, H. Y., Proliferating cell nuclear antigen (PCNA) as a marker of cell proliferation in the marine dinoflagellate Prorocentrum donghaiense Lu and the green alga Dunaliella salina Teodoresco. J. Appl. Phycol. 2005, 17, 323-330.
24. Ma, X. B., Jia, X. S., Liu, Y. L., Wang, L. L. et al., Expression and role of Notch signalling in the regeneration of rat tracheal epithelium. Cell Prolif. 2009, 42, 15-28.
25. Mitchell, K. E., Weiss, M. L., Mitchell, B. M., Martin, P. et al., Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003, 21, 50-60.
26. Prestegarden, L., Svendsen, A., Wang, J., Sleire, L. et al., Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res. 2010, 70, 4274-4279.
27. Rebetz, J., Tian, D., Persson, A., Widegren, B. et al., Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One 2008, 3, e1936.
28. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E. et al., Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63, 5821-5828.
29. Park, K. H., Choi, S. E., Eom, M., Kang, Y., Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships. Breast Cancer Res. 2005, 7, R238-R247.
30. Bentley, A. M., Williams, B. C., Goldberg, M. L., Andres, A. J., Phenotypic characterization of Drosophila ida mutants: defining the role of APC5 in cell cycle progression. J. Cell Sci. 2002, 115, 949-961.
31. Wang, Q., Moyret-Lalle, C., Couzon, F., Surbiguet-Clippe, C. et al., Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene 2003, 22, 1486-1490.
32. Haapasalo, H., Kylaniemi, M., Paunul, N., Kinnula, V. L., Soini, Y., Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol. 2003, 13, 155-164.
33. Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. et al., Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100, 15178-15183.
34. Shih, A. H., Holland, E. C., Notch signaling enhances nestin expression in gliomas. Neoplasia 2006, 8, 1072-1082.
35. Nefedova, Y., Sullivan, D. M., Bolick, S. C., Dalton, W. S., Gabrilovich, D. I., Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008, 111, 2220-2229.
36. Jia, X. X., Lu, Z. Z., Wang, H., Duan, H. F. et al., Suppressive effect of Notch signal activation on apoptosis of multiple myeloma cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004, 12, 335-339.
37. Lovat, P. E., Corazzari, M., Armstrong, J. L., Martin, S. et al., Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res. 2008, 68, 5363-5369.
38. Cui, Y., Zhu, H., Zhu, Y., Guo, X. et al., Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive. J. Proteome Res. 2008, 7, 3984-3993.
39. Pathil, A., Armeanu, S., Venturelli, S., Mascagni, P. et al., HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Hepatology 2006, 43, 425-434.
40. Singh, T. R., Shankar, S., Srivastava, R. K., HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. Oncogene 2005, 24, 4609-4623.
41. Zhao, Z. L., Li, Q. F., Zheng, Y. B., Chen, L. Y. et al., The aberrant expressions of nuclear matrix proteins during the apoptosis of human osteosarcoma cells. Anat. Rec. (Hoboken) 2010, 293, 813-820.
42. Xing, H., Zhang, S., Weinheimer, C., Kovacs, A., Muslin, A. J., 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. Embo J. 2000, 19, 349-358.
43. Rosenquist, M., 14-3-3 proteins in apoptosis. Braz. J. Med. Biol. Res. 2003, 36, 403-408.
44. Cao, W., Yang, X., Zhou, J., Teng, Z. et al., Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 2010, 15, 230-241.
45. Perez-Martinez, M., Gordon-Alonso, M., Cabrero, J. R., Barrero-Villar, M. et al., F-actin-binding protein drebrin regulates CXCR4 recruitment to the immune synapse. J. Cell Sci. 2010, 123, 1160-1170.
46. Betapudi, V., Myosin II motor proteins with different functions determine the fate of lamellipodia extension during cell spreading. PLoS One 2010, 5, e8560.
47. Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E., Treisman, R., Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 2009, 11, 257-268.
48. Cho, H. Y., Reddy, S. P., Debiase, A., Yamamoto, M., Kleeberger, S. R., Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med. 2005, 38, 325-343.
49. Gomez-Pastor, R., Perez-Torrado, R., Cabiscol, E., Ros, J., Matallana, E., Reduction of oxidative cellular damage by overexpression of the thioredoxin TRX2 gene improves yield and quality of wine yeast dry active biomass. Microb. Cell Fact. 2010, 9, 9.
50. Ronkainen, H., Vaarala, M. H., Kauppila, S., Soini, Y. et al., Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma. Oncol. Rep. 2009, 21, 1519-1523.
51. Go, Y. M., Craige, S. E., Orr, M., Gernert, K. M., Jones, D. P., Gene and protein responses of human monocytes to extracellular cysteine redox potential. Toxicol. Sci. 2009, 112, 354-362.
52. Kai, K., Arima, Y., Kamiya, T., Saya, H., Breast cancer stem cells. Breast Cancer 2010, 17, 80-85.
53. Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T. et al., Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458, 780-783.
54. Wakabayashi, N., Shin, S., Slocum, S. L., Agoston, E. S. et al., Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci. Signal 2010, 3, ra52.
55. Warburg, O., On the origin of cancer cells. Science 1956, 123, 309-314.
56. Palomero, T., Dominguez, M., Ferrando, A. A., The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 2008, 7, 965-970.
57. Ciofani, M., Zuniga-Pflucker, J. C., Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 2005, 6, 881-888.
58. Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R. et al., Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64, 3892-3899.
59. Vander Heiden, M. G., Cantley, L. C., Thompson, C. B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324, 1029-1033.
60. Kanamori, M., Kawaguchi, T., Nigro, J. M., Feuerstein, B. G. et al., Contribution of Notch signaling activation to human glioblastoma multiforme. J. Neurosurg. 2007, 106, 417-427.
61. Lee, S. H., Kim, M. H., Han, H. J., Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha. Am. J. Physiol. Cell Physiol. 2009, 297, C207-C216.